These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11711719)

  • 1. Two incorrect FDG positron emission tomographic interpretations of a pulmonary mass and mediastinal lymphadenopathy.
    Kao CH; Tsai SC; Hung GU
    Clin Nucl Med; 2001 Dec; 26(12):1049-50. PubMed ID: 11711719
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
    Gupta N; Gill H; Graeber G; Bishop H; Hurst J; Stephens T
    Chest; 1998 Oct; 114(4):1105-11. PubMed ID: 9792584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].
    Adams S; Nickel E; Hör G
    Nuklearmedizin; 2000 Aug; 39(5):N83-4. PubMed ID: 10984898
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of an adrenal mass in a patient with lung cancer by FDG coincidence positron emission tomography using a dual-head gamma camera.
    Pai M; Park CH; Yoon SN; Kim S; Whang KH
    Clin Nucl Med; 2000 Nov; 25(11):924-5. PubMed ID: 11079597
    [No Abstract]   [Full Text] [Related]  

  • 5. False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.
    Yoon SN; Park CH; Kim MK; Hwang KH; Kim S
    Clin Nucl Med; 2001 May; 26(5):461-2. PubMed ID: 11317035
    [No Abstract]   [Full Text] [Related]  

  • 6. [18F-fluorodeoxyglucose positron emission tomography (FDG-PET) negative poorly differentiated adenocarcinoma of lung with mediastinal lymph node metastases].
    Takahashi G; Noriyuki T; Shimoda K; Furonaka O; Osaki N; Shioya S; Yonehara S; Miyata Y
    Kyobu Geka; 2010 Dec; 63(13):1145-50. PubMed ID: 21174665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM; Gupta NC; Murray GF
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis.
    Beggs AD; Hain SF
    Clin Nucl Med; 2002 Oct; 27(10):705-6. PubMed ID: 12352111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
    Kim CH; Jeong JS; Kim SR; Choe YH; Park HS; Lee YC
    Am J Respir Crit Care Med; 2017 Sep; 196(5):652-654. PubMed ID: 28661181
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema.
    Duarte PS; Zhuang H; Machado C; Aldighieri F; Martins LR; Alonso G
    Clin Nucl Med; 2002 Aug; 27(8):605-6. PubMed ID: 12170014
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis.
    Muñoz MA; Conejo-Mir JS; Congregado-Loscertales M; Holgado C; Moya F; Loscertales J
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1418-9. PubMed ID: 17958854
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.
    Chen YK; Shen YY; Kao CH
    Clin Nucl Med; 2004 Apr; 29(4):281-3. PubMed ID: 15096984
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
    Lu P; Sun Y; Sun Y; Yu L
    Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.
    Cheng CY; Huang WS; Shen DH; Fan YM; Hsu HH; Cherng SC; Lee SC
    Clin Nucl Med; 2007 Feb; 32(2):117-21. PubMed ID: 17242565
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.
    Patz EF
    Radiographics; 2000; 20(4):1182-5. PubMed ID: 10903708
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans.
    Aitken CL; Mahmoud F; McGuinness G; Kramer EL; Maguire GQ; Noz ME
    Clin Nucl Med; 2002 Apr; 27(4):275-82. PubMed ID: 11914668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
    Kung J; Zhuang H; Yu JQ; Duarte PS; Alavi A
    Clin Nucl Med; 2003 Dec; 28(12):975-6. PubMed ID: 14663319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.